Latest Strategic Partnership News

Tartana Minerals progresses its Tartana-MGMF copper processing venture with key milestones achieved, steady copper sulphate production, and new financing secured from directors.

PARKD Limited has marked a strong finish to FY25 with the launch of innovative modular construction products and a national supply agreement, positioning itself for growth across Australia’s expanding infrastructure sectors.

Altamin Limited progresses its innovative Lazio lithium and sulphate of potash project with key engineering studies underway, while its Gorno base metals project reports exceptional zinc, lead, and silver assay results, setting the stage for strategic partnership discussions.

4DMedical has landed a $10 million strategic investment from Pro Medicus, aimed at accelerating its commercial growth and advancing its CT – VQ™ technology towards FDA clearance in the US.

Lithium Plus Minerals reports significant progress on its Lei Lithium Development Project alongside promising discoveries of beryllium and gold at its Arunta and Wingate projects, supported by a solid cash position of A$3.2 million.

Dart Mining reports its highest-ever gold assay at the Triumph Project alongside a new joint venture in Queensland, setting the stage for an expanded exploration campaign and a planned capital raise.

Macarthur Minerals has reported solid progress on its Lake Giles iron ore projects, confirming commercial viability and uncovering promising nickel targets, while securing A$2 million in fresh capital to support ongoing development.

Unibail-Rodamco-Westfield reports robust H1-2025 results with tenant sales growth, portfolio valuation gains, and strategic brand expansion underpinning confidence in full-year earnings guidance.

RocketBoots Limited has expanded its sales pipeline with five new customers covering over 8,550 locations and secured a strategic $1 million investment from Bombora Funds, positioning itself strongly in the growing AI retail technology market.

Quantum Graphite Limited has made significant strides in developing its Eyre Peninsula Graphite Hub, progressing detailed planning with government stakeholders and attracting new financiers for its Uley 2 project. Exploration and purification testwork updates promise to refine its resource and product quality outlook.

Adherium Limited reports a robust 30% increase in US remote patient monitoring users and closes a $4.5 million capital raise, positioning itself for accelerated growth under new leadership.

Vectus Biosystems confirms safety of its lead fibrosis drug VB0004 from Phase Ia/Ib trials and advances licensing talks globally, including in China, while managing costs and funding challenges.